Literature DB >> 21195727

Human papillomavirus vaccination rates and state mandates for tetanus-containing vaccines.

Amanda F Dempsey1, Sarah E Schaffer.   

Abstract

OBJECTIVE: We sought to examine nationally the association between school mandates for adolescent tetanus-containing vaccines (Td and/or Tdap) and adolescent female human papillomavirus (HPV) vaccination.
METHODS: Each state was categorized by whether a school mandate for adolescent Td and/or Tdap vaccines was enacted. Mean HPV vaccine series initiation levels among adolescent females were compared between each mandate category.
RESULTS: Mean HPV vaccine series initiation levels were significantly lower in states without Td/Tdap vaccine mandates than in those with mandates (42.9% vs. 47.3%; p=0.004).
CONCLUSIONS: School mandates for adolescent Td/Tdap vaccination may have a carry-over effect on HPV vaccination.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21195727      PMCID: PMC3062651          DOI: 10.1016/j.ypmed.2010.12.010

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  8 in total

Review 1.  Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults. The Task Force on Community Preventive Services.

Authors:  P A Briss; L E Rodewald; A R Hinman; A M Shefer; R A Strikas; R R Bernier; V G Carande-Kulis; H R Yusuf; S M Ndiaye; S M Williams
Journal:  Am J Prev Med       Date:  2000-01       Impact factor: 5.043

2.  Changes in Tdap and MCV4 vaccine coverage following enactment of a statewide requirement of Tdap vaccination for entry into sixth grade.

Authors:  Elyse Olshen Kharbanda; Melissa S Stockwell; James Colgrove; Karthik Natarajan; Vaughn I Rickert
Journal:  Am J Public Health       Date:  2010-07-15       Impact factor: 9.308

3.  National, state, and local area vaccination coverage among adolescents aged 13-17 years --- United States, 2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2010-08-20       Impact factor: 17.586

4.  The impact of a school entry law on adolescent immunization rates.

Authors:  Thad R Wilson; Daniel B Fishbein; Peggy A Ellis; Stanley A Edlavitch
Journal:  J Adolesc Health       Date:  2005-12       Impact factor: 5.012

5.  Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system.

Authors:  Amanda Dempsey; Lisa Cohn; Vanessa Dalton; Mack Ruffin
Journal:  Vaccine       Date:  2009-11-17       Impact factor: 3.641

6.  Vaccination coverage among children in kindergarten--United States, 2006-07 school year.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2007-08-17       Impact factor: 17.586

7.  The impact of state policies on vaccine coverage by age 13 in an insured population.

Authors:  Elyse Olshen; Barbara E Mahon; Shuang Wang; Elizabeth R Woods
Journal:  J Adolesc Health       Date:  2007-03-09       Impact factor: 5.012

Review 8.  The HPV vaccine mandate controversy.

Authors:  Gillian Haber; Robert M Malow; Gregory D Zimet
Journal:  J Pediatr Adolesc Gynecol       Date:  2007-12       Impact factor: 1.814

  8 in total
  4 in total

Review 1.  The rise (and fall?) of parental vaccine hesitancy.

Authors:  Charitha Gowda; Amanda F Dempsey
Journal:  Hum Vaccin Immunother       Date:  2013-06-06       Impact factor: 3.452

2.  Multilevel correlates for human papillomavirus vaccination of adolescent girls attending safety net clinics.

Authors:  Jasmin A Tiro; Sandi L Pruitt; Corinne M Bruce; Donna Persaud; May Lau; Sally W Vernon; Jay Morrow; Celette Sugg Skinner
Journal:  Vaccine       Date:  2011-11-21       Impact factor: 3.641

3.  School Entry Requirements and Coverage of Nontargeted Adolescent Vaccines.

Authors:  Jennifer L Moss; Paul L Reiter; Young K Truong; Barbara K Rimer; Noel T Brewer
Journal:  Pediatrics       Date:  2016-11-08       Impact factor: 7.124

Review 4.  Interventions to increase HPV vaccination coverage: A systematic review.

Authors:  Elizabeth A Smulian; Krista R Mitchell; Shannon Stokley
Journal:  Hum Vaccin Immunother       Date:  2016-02-02       Impact factor: 3.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.